Tissue GNAS mutations are associated with IPMN (58–79%; OR 30, 95% CI 7.143–127.622), IPMN-associated adenocarcinoma (36%) and mucinous carcinoma (78%) [71–74]. This evidence concerns the gene GNAS and pancreatic intraductal papillary-mucinous neoplasm.